Clinical Trial Update: Botulinum Toxin Type A for Treating Allodynic Pain in SCI and MS [Phase 2]

View source ↗

Summary

Phase 2 trial investigating botulinum toxin type A for allodynic pain in spinal cord injury and multiple sclerosis; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allodynia
• Multiple Sclerosis
• Neuropathic Pain
• Spinal Cord Injury

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: University of Manitoba | Conditions: Neuropathic Pain, Allodynia | Phase 2 | Status: TERMINATED